QUARTERLY REPORT

Company

Actinium Pharmaceuticals, Inc.

Filed

August 8, 2025

Period of Report

June 30, 2025

Accession Number

0001213900-25-073743

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →